Sebia USA

Join Sebia this month at regional tradeshows near you to explore the latest in laboratory diagnostics and discover how our innovations support better patient outcomes. 📍 April 3–4 – Colorado & Wyoming ASCLS | Denver, CO 📍 April 7–8 – ASCP Knowledge Lab | Fort McDowell, AZ 📍 April 15–16 – Iowa CoLABoration | Cedar Rapids, IA 📍 April 22–23 – ASCLS Wisconsin State Convention | Madison, WI Stop by and connect with our team to learn more about Sebia’s solutions and how we’re advancing clinical diagnostics. 🔬 #Sebiausa #LabInnovation #ClinicalDiagnostics #LabProfessionals #MedicalTechnology #ASCLS #ASCP #LabConference #AprilEvents

It is now possible to 𝐦𝐨𝐧𝐢𝐭𝐨𝐫 𝐌𝐢𝐧𝐢𝐦𝐚𝐥 𝐑𝐞𝐬𝐢𝐝𝐮𝐚𝐥 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 (MRD) in 𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐌𝐲𝐞𝐥𝐨𝐦𝐚 with a simple blood draw🩸. #MRD negativity is associated with better clinical outcomes. 🔬Current techniques for #𝐌𝐑𝐃 𝐞𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 require painful bone marrow aspirate and provide limited MRD timepoints. ✨𝐌-𝐢𝐧𝐒𝐢𝐠𝐡𝐭 is a next generation investigational LDT test used in clinical trials to elevate MRD testing to a new standard of excellence. ✔️𝐂𝐡𝐞𝐜𝐤 𝐨𝐮𝐭 𝐨𝐮𝐫 𝐥𝐚𝐬𝐭 𝐩𝐨𝐬𝐭𝐞𝐫 presented and discover other publications related to 𝐌𝐑𝐃 𝐭𝐫𝐚𝐜𝐤𝐢𝐧𝐠 𝐢𝐧 𝐛𝐥𝐨𝐨𝐝 𝐢𝐧 𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐌𝐲𝐞𝐥𝐨𝐦𝐚 on our website: https://lnkd.in/eE2hZEGA #MassSpectrometry #MinimalResidualDisease #MyelomaActionMonth #MyelomaAwarenessMonth #MultipleMyeloma #MinSight #Sebiausa

Did you watch our Sebia #webinar 𝐑𝐞𝐜𝐞𝐧𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐢𝐧𝐭𝐨 𝐒𝐞𝐫𝐮𝐦 𝐅𝐫𝐞𝐞 𝐋𝐢𝐠𝐡𝐭 𝐂𝐡𝐚𝐢𝐧 𝐀𝐬𝐬𝐚𝐲𝐬 𝐟𝐨𝐫 𝐏𝐥𝐚𝐬𝐦𝐚 𝐂𝐞𝐥𝐥 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬 yet? 🎥 Don't worry, you can watch the replay now: https://lnkd.in/ebWt8Uhh 🎙️ Dr. Willrich and Dr. Dispenzieri from Mayo Clinic (USA) have recently shared insights into Serum Free Light Chain assays for plasma cell disorders. #MyelomaAwareness #CancerAwareness #Diagnostics #HealthcareInnovation #BloodCancer #MultipleMyeloma #Sebia

🚨 Exciting March 2025 Events! 🚨 Join Sebia at these upcoming tradeshows & conferences to explore our cutting-edge solutions for laboratory needs. 📍 March 17-18 – ASCLS CNE 76th Clinical Laboratory Science Convention, Warwick, RI 📍 March 24-25 – Ohio Collaborative Laboratory Conference, Westerville, OH 📍 March 25-26 – ASCP Great Plains 2025 Spring Meeting, Omaha, NE 🔬 Stop by our booth to learn how Sebia's advanced diagnostic solutions can support your lab’s efficiency and precision. See you there! #SebiaUSA #MultipleMyeloma #A1c #FLC #LabSolutions #ClinicalDiagnostics #MedicalLaboratory #ASCLS #ASCP #OhioLabs #NewEnglandLabs #NebraskaLabs

Did you know? HbA1c testing cannot be accurately measured in individuals without Hb A—such as those with homozygous hemoglobin variants (Hb SS, Hb EE, etc.). In these cases, alternative glycated proteins like fructosamine or glycated albumin should be considered. 🔬 This recommendation from Page 28 of the laboratory guidelines for diabetes diagnosis and management ensures accurate testing and better patient care. 📢 Stay informed, stay precise! 👉 Learn more: https://lnkd.in/dDPuw8AW #DiabetesManagement #LabGuidelines #HemoglobinVariants #HbA1c #Sebiausa

🔬 𝐒𝐞𝐫𝐮𝐦 𝐏𝐫𝐨𝐭𝐞𝐢𝐧 #𝐄𝐥𝐞𝐜𝐭𝐫𝐨𝐩𝐡𝐨𝐫𝐞𝐬𝐢𝐬 (#𝐒𝐏𝐄) is a crucial component of international guidelines for the #𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 and #𝐦𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 of Multiple #Myeloma patients. Learn more about the Sebia Myeloma diagnosis journey with ➡️ https://lnkd.in/dWk-pAVr #MyelomaAwareness #EarlyDiagnosis #HealthcareInnovation #BloodCancer #MultipleMyeloma #MyelomaPatients #PatientCare #Sebia

Don't miss our March 11th webinar featuring two leading experts who will compare the performance of sFLC assays in the contexts of Multiple Myeloma, including its precursors such as MGUS and smoldering myeloma, and Amyloidosis. With the introduction of updated guidelines for monoclonal gammopathies and a new, 2023 consensus for cardiac amyloidosis, attendees will gain valuable insights into the interchangeability of assay platforms and key considerations for optimizing testing triage. Earn Continuing Education (CE) credits for participating in this webinar. Register for free today! Sebia USA

Don't Miss this! 𝐄𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐖𝐞𝐛𝐢𝐧𝐚𝐫 𝐒𝐞𝐫𝐮𝐦 𝐅𝐫𝐞𝐞 𝐋𝐢𝐠𝐡𝐭 𝐂𝐡𝐚𝐢𝐧 Tomorrow: 𝐌𝐚𝐫𝐜𝐡 𝟏𝟏, 𝟐𝟎𝟐𝟓 🕛 12:00 PM EDT 𝐑𝐞𝐜𝐞𝐧𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐢𝐧𝐭𝐨 𝐒𝐞𝐫𝐮𝐦 𝐅𝐫𝐞𝐞 𝐋𝐢𝐠𝐡𝐭 𝐂𝐡𝐚𝐢𝐧 𝐀𝐬𝐬𝐚𝐲𝐬 𝐟𝐨𝐫 𝐏𝐥𝐚𝐬𝐦𝐚 𝐂𝐞𝐥𝐥 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬 🎤 Guest speakers: 𝐃𝐫. 𝐌𝐚𝐫𝐢𝐚 𝐖𝐢𝐥𝐥𝐫𝐢𝐜𝐡 𝐚𝐧𝐝 𝐃𝐫. 𝐀𝐧𝐠𝐞𝐥𝐚 𝐃𝐢𝐬𝐩𝐞𝐧𝐳𝐢𝐞𝐫𝐢 ▪️RSVP Today!: https://lnkd.in/eezBp9-V Not available at this time? No worries! By registering, you’ll get access to the replay. 🎥 #FLC #FreeLightChains #CardiacAmyloidosis #FreeLightChain #MonoclonalProteins #ClinicalDiagnostics #LabMedicine #HealthcareInnovation #Webinar #Sebia

Sebia USA joins the #MyelomaActionMonth, to raise awareness of #𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞𝐌𝐲𝐞𝐥𝐨𝐦𝐚 𝐭𝐡𝐞 𝟐𝐧𝐝 𝐦𝐨𝐬𝐭 𝐜𝐨𝐦𝐦𝐨𝐧 𝐛𝐥𝐨𝐨𝐝 𝐜𝐚𝐧𝐜𝐞𝐫 in the World. 🔬#Sebia takes action in 𝐞𝐚𝐫𝐥𝐲 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 𝐚𝐧𝐝 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐦𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 for better patient management. Let's raise awareness together! 👉 Discover more about Sebia's solutions: https://lnkd.in/ddDWcC3d #MyelomaAwareness #CancerResearch #MultipleMyeloma #Diagnosis #MyelomaMilestone #MyelomaPatients #PatientCare

🔬 Sensitive times call for sensitive measures! 🔬 When it comes to diagnosing Multiple Myeloma (MM) and AL Amyloidosis (AL), accuracy matters. The Sebia sFLC Assay delivers a 17% higher specificity compared to other free light chain (#FLC) assays, ensuring more reliable results for patients and healthcare providers. 📊 Key Findings: ✔️ 96.6% Sensitivity for MM ✔️ 91% Sensitivity for AL ✔️ 85.1% Specificity – a 17% higher specificity over other assays Precision in diagnosis means better patient care and outcomes. Learn more about how Sebia is advancing FLC testing. --> https://lnkd.in/gn7-F52P #Sebia #FreeLightChain #MultipleMyeloma #ALAmyloidosis #Sensitivity #Specificity #DiagnosticInnovation #TheNewLanguageOfLife #Sebiausa